Medline (MDLN) share buybacks: $33M
Medline spent $33M buying back its own shares in the year ended Dec 31, 2025, up 65.0% from $20M a year earlier.
From Medline's filings with the SEC · Read the filing · MDLN stock page
Medline share buybacks by year
#1,092 of 1,890 US companies by share buybacks · See the full ranking
| Year ended | Share buybacks | Change |
|---|---|---|
| Dec 31, 2025 | $33M | +65% |
| Dec 31, 2024 | $20M | – |
Share buybacks of similar companies
Companies in the same industry as Medline, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.
| Company | Share buybacks, latest year | Year ended |
|---|---|---|
| Inspire Medical Systems | $175M | Dec 31, 2025 |
| Haemonetics | $175M | Mar 28, 2026 |
| West Pharmaceutical Services | $134M | Dec 31, 2025 |
| Insulet | $59.6M | Dec 31, 2025 |
| Medline | $33M | Dec 31, 2025 |
| Icu Medical | $8.8M | Dec 31, 2025 |
| Delcath Systems | $6M | Dec 31, 2025 |
Questions and answers
What is Medline's share buybacks?
Medline spent $33M buying back its own shares in the year ended Dec 31, 2025, up 65.0% from $20M a year earlier.
Numbers as reported in Medline's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology